NLRP3 and COVID-19: Virus-infection-induced ALI/ARDS was an active area of research, and with the epidemic outbreak of COVID-19, research on the role and therapeutic potential of NLRP3 inflammasome in COVID-19-associated ALI/ARDS was emerging as a hot topic, which is still necessary to explore in the future.